Prions, self-propagating protein structures that can be transmitted between cells and different organisms, usually consist of ordered protein aggregates. Alberti et al. (2009) now present a systematic approach for the discovery of new prions that expands the spectrum of their biological functions.
Prions are protein aggregates that are propagated by the concentration-and nucleation-dependent conversion of soluble prionogenic proteins into prion aggregates that often adopt a cross-β sheet-rich (amyloid) structure (Prusiner, 1998) . Given their capacity to propagate themselves, prions can be transmitted between cells and organisms by mechanisms that are only beginning to be understood. Indeed, pathological prions cause Kuru, a human prion disease associated with cannibalism. In this and other prion diseases, the aggregated form of the prion protein efficiently recruits the soluble form of the prion protein into the structured aggregate (prion particle), enabling propagation. Until relatively recently, prions derived from the translation termination factor Sup35p in the budding yeast Saccharomyces cerevisiae were the only examples of amyloid-like aggregates thought to have normal cellular functions. However, it is now clear that amyloid and amyloid-like aggregates can perform a variety of important biological functions in addition to their involvement in neurodegenerative diseases such as Alzheimer's disease (Fowler et al., 2006) . Given that functional amyloids have highly divergent sequences and that there is a paucity of effective tools to identify them, we have likely seen only the tip of the iceberg. In this issue, Alberti et al. (2009) deploy an elegant combination of bioinformatics and biological assays to identify and characterize prion candidates in S. cerevisiae, thereby making a significant contribution toward understanding new prions that have the potential for normal cellular functions.
Alberti and colleagues begin their systematic approach by searching the yeast genome for candidate prion domains. The authors use a bioinformatics algorithm (hidden Markov model) based on sequence information from the known yeast prions Sup35p, Ure2p, and Rnq1p. This method is complementary to that used in a previous study to survey a variety of organisms for the glutamine/ asparagine (Gln/Asn)-rich sequences characteristic of yeast prions (Michelitsch and Weissman, 2000) . As the authors acknowledge, basing the algorithm on the known yeast prions does result in a bias toward finding prion domains with Gln/ Asn-rich motifs. Hence, the approach will likely underestimate the number of yeast prions, given that some non-Gln/Asnbased prion domains are known (such as the fungal Het-S prion). However, Gln/ Asn-based prion domains are present in a large category of important proteins and the presence of Gln/Asn-rich sequence motifs remains a necessary assumption for building sequence-based models of prionogenicity.
From their search results, Alberti and colleagues closely examined the top 100 candidate prion domains that are greater than 60 residues in length. To validate these proteins as prions, the authors assessed them for their ability to form aggregates in vivo under physiological conditions, for their propensity to form amyloid in vitro in the absence of the influence of the protein homeostasis (proteostasis) network, and for their ability to be heritably propagated in cells. Of the top 100 candidate prions, 69 proteins aggregate when overexpressed in yeast, as indicated by the formation of puncta in the cells. Furthermore, 50% of the candidate proteins, when purified from yeast cells, exhibit resistance to denaturation in the presence of sodium dodecyl sulfate (SDS), a characteristic property of cross-β sheet-rich prions and amyloids. In vitro aggregation assays show that half of the candidate proteins are also able to nucleate and form aggregates within 72 hr, as indicated by the ability of the purified proteins to bind to the amyloid-binding fluorophore thioflavin T. These protein aggregates are also SDS resistant, further indicating that they are not amorphous but have robust quaternary structures such as cross-β sheet structures.
To assay whether any of the prion domain candidate proteins could be heritably propagated, Alberti and colleagues developed an assay based on the translation termination factor Sup35p, one of the best understood functional prions. In the aggregated state, Sup35p ceases to function, enabling stop codon readthrough. This leads to a [PSI+] cell phenotype that can be transmitted to daughter cells and thus constitutes a means of non-Mendelian, protein-based phenotype inheritance (Wickner, 1994 (Patel et al., 2009; Nemecek et al., 2009) were also identified as likely candidates by Alberti et al.
Analysis of the prion domain sequences also reveals that asparagine residues are highly enriched among the identified aggregation-prone prion domains, whereas glutamine-rich sequences occur less frequently and thus seem less prone to aggregation. This amino-acid bias is a remarkable and unexpected finding. Further study is required to understand this result, as it is not immediately obvious why sequences rich in glutamine residues (with an additional CH2 group compared to asparagine) would be less prionogenic, especially given that there are numerous polyglutamine aggregation diseases, such as Huntington's disease.
In their study, Alberti and colleagues also rigorously characterized Mot3p, one of the more interesting candidate prion proteins. Mot3p is a transcription factor that modulates a variety of processes, including mating, carbon metabolism, and the stress response.
Alberti et al. demonstrate that Mot3p is also a yeast prion in its native environment. As expected, maintenance of the Mot3p prion state requires Hsp104p to fragment the amyloid-like Mot3p aggregates, promoting inheritance of aggregate seeds and thus the prion phenotype. The authors find that the aggregated state of Mot3p influences its regulation of a cell wall remodeling program during adaptation to anaerobic conditions. This indicates that the prion form of the protein could confer a fitness advantage in certain environments.
That the yeast prions identified in the study of Alberti et al. and elsewhere influence the processes of transcription and translation in the cell support the hypothesis that prions have normal cellular functions. Furthermore, it is possible that prions could promote phenotypic variability within a population of cells. The current work not only suggests that multiple functional prion proteins exist in the yeast cell, but that these prions share a common proteostasis regulatory network consisting of Hsp104p and Rnq1p (Balch et al., 2008) . The study underscores that, in yeast, the regulatory network for proteostasis is important in determining whether an aggregate can be efficiently propagated to a daughter cell or not (for example, Hsp104p is known to be critical for efficient fungal prion propagation) (Chernoff et al., 1995) (Figure 1 ). This observation raises questions about whether nonpropagating amyloid diseases and propagating prion diseases in humans are truly distinct, or whether they represent a continuum of possibilities dictated by the sequence of the peptide, the structure of the aggregate, as well as the many activities that comprise the proteostasis network and the extent to which stress-responsive signaling pathways are activated (Balch et al., 2008) . Indeed, the amyloid disease proteins that harbor prion-like domains were examined in functional assays for their ability to aggregate both in vivo and in vitro as well as to replicate as prions in cells. A total of 18 candidate proteins were shown to contain bona fide prion domains. (Bottom) Mot3p was identified as a candidate prion. Mot3p is a transcriptional repressor of anaerobic genes and influences mating, carbon metabolism, stress response, and cell wall adaptation to anaerobic conditions. Alberti et al. show that Mot3p aggregation in yeast cells leads to heritable cell wall-related phenotypes. The propagation capacity of prions, including Mot3p, is controlled by components of the protein homeostasis network (such as the prion fragmentor Hsp104p) and physical properties of the prion aggregate (such as the presence of asparagine-or glutamine-rich sequences).
reactive amyloidosis exhibits features of a prion disease. Aggregate fibrils consisting of serum amyloid A, a protein whose overexpression in humans and other animals can lead to reactive amyloidosis, are capable of recruiting soluble serum amyloid A in a process that appears to spread the amyloid throughout the organism (Johan et al., 1998) .
Further study of functional amyloid and prions will undoubtedly provide insights into the etiology of amyloid and prion diseases by educating us about the means by which biological systems can harness amyloid and prions without deleterious effects from the aggregates. A significant achievement in this effort would be the development of a general method to characterize amyloid and prions in different organisms solely based on their structural and functional attributes without regard to their sequences. In combining a computational approach with a variety of functional assays to identify numerous new prion sequences, the work of Alberti et al. has brought us one step closer to this goal.
Adipose tissue is central to the control of energy homeostasis. Although white adipose tissue acts primarily as a site of fat storage, it also communicates with peripheral and central sites in times of excess or insufficient food supply through the release and action of a variety of adipokines, including adiponectin and leptin (Dahlman and Arner, 2007) . In contrast, brown adipose tissue protects against obesity through the action of β-adrenergic stimulation and thyroid hormone in regulating adaptive thermogenesis due to mitochondrial uncoupling (Cannon and Nedergaard, 2004) . Brown adipose tissue has a high density of mitochondria and elevated oxidative capacity. Brown fat also expresses uncoupling protein 1 (UCP1), which plays a pivotal role in adaptive thermogenesis by uncoupling the mitochondrial protein gradient from ATP production. PPARγ coactivator-1α (PGC-1α) is a key coordinator of gene regulatory responses that promote mitochondrial biogenesis and thermogenic programs in brown adipose tissue, as well as in skeletal muscle. PGC-1α carries out these functions through its interaction with members of the nuclear receptor family of proteins, including peroxisome proliferator-activated receptor δ (PPARδ) (Puigserver et al., 1998) . In this issue, Pan et al. (2009) show that twist-1 is a negative feedback regulator of PGC-1α/PPARδ-mediated brown fat metabolism. This regulation controls mitochondrial metabolism and uncoupling and has implications for energy homeostasis in obesity (Figure 1) .
Twist-1 is a highly conserved transcription factor that belongs to the basic helix-loop-helix (bHLH) family of proteins (Thisse et al., 1987) . It acts as a regulator of various processes including early development, apoptosis, cancer, and osteoblast differentiation (Sosic and Olson, 2003) . In humans, a germline mutation in the coding sequence of twist-1, which results in haploinsufficiency, is respon-
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